Clinical Trials · NCT00068601

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
SWOG Cancer Research Network
Enrollment
257
Start date
Oct 2003
Locations
34 sites, 6 countries
Primary endpoint
Rate of Premature Ovarian Failure at 2 Years
View Gonadorelin compound reference